Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

NCT00005842

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

Institute for Drug Development San Antonio, Texas, United States

View Trial Details

Completed

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

NCT00002625

Conditions: Bronchial Neoplasms, Burkitt Lymphoma, Carcinoma, Bronchogenic, +52 more
Locations: University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer

NCT00004126

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

University of Chicago Cancer Research Center Chicago, Illinois, United States

Louis A. Weiss Memorial Hospital Chicago, Illinois, United States

Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States

View Trial Details

Completed

Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer

NCT00002537

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States

View Trial Details

Completed

Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

NCT00009971

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, +8 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

NCT00025389

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

NCT00005849

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

University of Chicago Cancer Research Center Chicago, Illinois, United States

Louis A. Weiss Memorial Hospital Chicago, Illinois, United States

Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States

View Trial Details

Completed

A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone

NCT00265317

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Mobile, Alabama, United States

Pfizer Investigational Site Antioch, California, United States

View all 32 locations

View Trial Details

Completed

Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer

NCT00014066

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim

NCT00280787

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions